Viral infections can raise prostate-specific antigen levels, sometimes substantially. PSA is often treated as a cancer-screening number, so an unexpected spike can be alarming, but inflammation from a virus is one of several non-cancerous reasons the reading climbs. Research on specific viruses, from common herpes-family infections to SARS-CoV-2, shows that the effect is real, measurable, and in some cases lingers longer than most people expect.
How Inflammation Pushes PSA Into the Bloodstream
PSA is a protein made by cells lining the prostate. Under normal conditions, most of it stays within the gland and drains into semen. When the prostate tissue becomes inflamed, whether from bacteria, a virus, or some other irritant, the barrier between the gland’s interior and the bloodstream breaks down. Damaged epithelial cells release PSA into surrounding tissue, and inflamed blood vessels become more permeable, letting the protein leak into circulation. This is the core reason any infection in or near the prostate can push a blood PSA reading upward.
A study of men with PSA under 4 ng/mL and no cancer found that both acute and chronic inflammation within the prostate were independently associated with higher serum PSA, and the key factor was disruption of the epithelial lining rather than the sheer volume of inflammatory cells present.1PubMed Central. Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng/mL, normal DRE, and negative for prostate cancer Separate biopsy work confirmed that subclinical inflammation, the kind with no outward symptoms, is present in nearly every set of prostate biopsies, and that even this low-grade, silent inflammation can be enough to bump the number.2PubMed. Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density The implication is straightforward: you do not need a raging infection or painful symptoms for a virus to influence your PSA. A quiet inflammatory response in the prostate is enough.
Viruses That Have Been Directly Linked to PSA Elevation
Not every virus behaves the same way with respect to the prostate. Some infect the gland directly, some trigger systemic inflammation that affects it indirectly, and some appear to have no measurable impact on PSA at all. The evidence is strongest for a handful of specific pathogens.
Human Herpesvirus 8 (HHV-8)
HHV-8, best known as the virus behind Kaposi sarcoma, has one of the clearer statistical links to elevated PSA. In a study of men from Tobago, those with an elevated PSA were roughly two and a half times more likely to be seropositive for HHV-8 than age-matched cancer-free controls. The elevated-PSA group also had higher levels of circulating inflammatory cytokines, suggesting the virus was driving a broad pro-inflammatory immune response that spilled over into prostate tissue.3PubMed Central. Elevated Serum PSA Is Associated With Human Herpesvirus 8 Infection and Increased Circulating Cytokine Levels in Men From Tobago HHV-8 is not a common infection in most Western populations, but among men in regions where it circulates more widely, it represents a genuine confounding factor in PSA interpretation.
Epstein-Barr Virus and Infectious Mononucleosis
Epstein-Barr virus, the cause of infectious mononucleosis (“mono”), offers perhaps the most striking evidence that a virus does not even need to infect the prostate to raise PSA. A study comparing men hospitalized with mono to controls found that about one in five mono patients experienced a PSA rise of 20 ng/mL or more, compared to fewer than one in ten controls. A rise of 40 percent or greater occurred in about a quarter of mono patients versus fewer than one in ten controls.4PubMed. Infectious mononucleosis, other infections and prostate-specific antigen concentration as a marker of prostate involvement during infection EBV does not typically target the prostate. The researchers suggested that the PSA jump reflects systemic inflammation rather than direct prostatic infection, a finding with broad implications: if a severe enough immune response anywhere in the body can raise PSA, then many acute viral illnesses could theoretically do the same.
Cytomegalovirus (CMV)
CMV, another herpes-family virus, has been found in prostate tissue. A documented case involved a heart transplant recipient whose elevated PSA prompted a biopsy. The biopsy revealed both adenocarcinoma and chronic prostatitis with viral changes consistent with CMV infection.5PubMed. Cytomegalovirus prostatitis in a heart transplant recipient This is a case report rather than a large study, and the patient was immunosuppressed, so it does not prove that CMV raises PSA in the general population. But it demonstrates that CMV can directly infect the prostate and coexist with cancer, making the clinical picture harder to sort out. For organ transplant recipients and others on immunosuppressive therapy, the possibility of CMV-driven PSA elevation is worth keeping in mind during screening.
SARS-CoV-2 (COVID-19)
COVID-19 added a new wrinkle to PSA interpretation starting in 2020. The prostate’s epithelial cells express ACE2 and TMPRSS2, the same surface proteins that SARS-CoV-2 uses to enter cells in the lungs. This gives the virus a plausible route into prostate tissue. Once there, the infection can downregulate ACE2’s normal anti-inflammatory role, triggering inflammation in the gland and a subsequent rise in PSA.6QJM: An International Journal of Medicine. Elevated prostate-specific antigen (PSA) levels from acute COVID-19 infection confounding cancer disease surveillance For men who had a PSA test around the time of a COVID infection, clinicians now generally recommend waiting and retesting rather than acting on a single elevated reading.
COVID Vaccination and PSA
The connection does not stop at the infection itself. Research on COVID-19 vaccination found that the mRNA vaccines were associated with a statistically significant increase in PSA levels, with the third (booster) dose having the most pronounced effect. The proposed explanation involves the heightened immune response triggered by the booster: stronger reactogenicity can lead to subclinical prostatitis or coagulation-related tissue damage in the prostate, both of which could release PSA into the blood.7PubMed Central. Prostate-specific antigen level association with COVID-19 infection and vaccination The increase appears to be temporary, but if your PSA test happened to fall shortly after a booster dose, you could get a result that looks concerning but is really just your immune system doing its job.
This finding carries a practical lesson that extends beyond COVID vaccines. Any vaccine or illness that provokes a robust systemic immune response has the theoretical potential to nudge PSA upward. The effect is probably small for most routine vaccinations, but it reinforces why timing matters when scheduling a PSA blood draw.
Viruses That Do Not Seem to Raise PSA
Not every virus with a link to the prostate appears to affect PSA. Human papillomavirus (HPV) has been investigated as a possible risk factor for prostate cancer, but one case-control study found no significant association between HPV infection and PSA levels.8Archives of Clinical Infectious Diseases. Infection with Human Papillomavirus as a Potential Risk Factor for Prostate Cancer: A Case-control Study HPV tends to infect surface epithelial cells without triggering the kind of deep-tissue inflammatory disruption that releases PSA into the bloodstream, which may explain the null result.
HIV is another case where the intuition might not match the data. A study of older men with or at risk of HIV infection found no significant difference in the proportion of elevated PSA between HIV-positive and HIV-negative men. The only factor significantly associated with elevated PSA was older age.9PubMed Central. Serum prostate-specific antigen levels in older men with or at risk of HIV infection HIV does not appear to directly infect prostate tissue or cause the local inflammation that drives PSA leakage. Of course, HIV-related immunosuppression can make a person more susceptible to opportunistic infections that might independently affect the prostate, but HIV itself does not seem to be the culprit.
Infections Can Affect PSA for Years, Not Just Weeks
One of the more surprising findings in this area is that the influence of infections on PSA is not always a brief blip. An analysis tracking men over an average of ten years found that those with documented histories of sexually transmitted infections, systemic infections, or any infections combined were significantly more likely to show a PSA increase over the follow-up period than men with no infection history. About two-thirds of men with past STIs showed some PSA rise, compared to about 55 percent of controls, and the pattern held for systemic infections as well.10PubMed Central. Sustained influence of infections on prostate-specific antigen concentration: An analysis of changes over 10 years of follow-up
This does not mean a single bout of the flu will permanently alter your PSA trajectory. But it does suggest that repeated infections or certain chronic infections can leave a lasting mark on the prostate’s inflammatory environment, gradually nudging baseline PSA higher over time. For men with a history of urogenital or systemic infections, this long-term drift is worth considering when interpreting a screening result.
Why a Single Elevated PSA Should Not Trigger Immediate Alarm
Given everything above, it should not surprise you that guidelines generally advise against acting on a single elevated PSA reading. A raised level can reflect cancer, but it can also reflect a recent infection, inflammation, vigorous exercise, sexual activity, or even the normal day-to-day fluctuation of the protein in your blood. A confirmatory repeat test, typically after a few weeks, helps sort out whether the elevation is persistent or transient.11PubMed Central. Prostate specific antigen test must be repeated before biopsy
If you recently had a viral illness, particularly one with significant symptoms like fever, fatigue, or body aches, mention it to your doctor before drawing conclusions from a PSA result. In many cases, the simplest next step is to wait for the infection to clear and then retest. A PSA that normalizes on its own is reassuring. One that stays elevated or keeps climbing warrants further investigation.
When Treatment Brings PSA Back Down
Much of the clinical data on treating infection-related PSA elevation comes from bacterial prostatitis rather than viral infection, largely because bacterial prostatitis is more common and more treatable. In one study of men with chronic prostatitis and PSA above 4 ng/mL, six weeks of antibiotics and anti-inflammatory drugs brought the average PSA down by roughly 42 percent, and about half of the men saw their PSA drop below the 4 ng/mL threshold.12PubMed Central. Does normalizing PSA after successful treatment of chronic prostatitis with high PSA value exclude prostatic biopsy? Importantly, though, a PSA that normalizes after anti-inflammatory treatment does not guarantee the absence of cancer. In the same study, cancer was still found in some men whose PSA had come down, particularly when it had been high to begin with.
For viral infections, there is no equivalent of a simple antibiotic course that resolves the inflammation. Antiviral drugs exist for herpes-family viruses and can help in specific clinical situations, but most viral prostatitis or viral-driven PSA elevation is managed by waiting for the immune system to clear the infection and recheck PSA afterward. Anti-inflammatory medications may help in the meantime, though their specific benefit for viral PSA elevation has not been well studied.
The Diagnostic Puzzle When Cancer and Infection Coexist
One of the trickiest clinical scenarios is when a virus-driven PSA rise is dismissed as benign but cancer is actually present, or conversely, when an infection-driven spike leads to unnecessary biopsies. The CMV case mentioned earlier illustrates the first problem: a transplant patient had both viral prostatitis and adenocarcinoma, and separating the contributions of each to his PSA was not straightforward.5PubMed. Cytomegalovirus prostatitis in a heart transplant recipient On the other side, the EBV data show that a substantial minority of men with mono experience PSA jumps large enough to trigger concern about cancer, even though the elevation is entirely infection-related.4PubMed. Infectious mononucleosis, other infections and prostate-specific antigen concentration as a marker of prostate involvement during infection
There is no perfect test to distinguish virus-driven PSA from cancer-driven PSA in a single blood draw. Free-to-total PSA ratio, PSA density (which accounts for prostate size), and PSA velocity (the rate of change over time) all provide additional clues but none are definitive. The practical approach most clinicians follow is to treat or wait out any known infection, retest, and proceed to biopsy only if the PSA stays elevated or rises further once the infectious cause has been addressed.
Molecular Detection of Viruses in Prostate Tissue
Researchers have tried to settle the question of which viruses actually inhabit the prostate by looking for viral DNA in tissue samples. A molecular analysis of prostate tissue from cancer patients tested for several viruses, including EBV, CMV, HPV, and BK virus, using organism-specific PCR. In general, the PCR assays failed to detect multiple organisms that had previously been reported as common in the prostate.13PubMed Central. A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms This result does not mean those viruses never infect the prostate. It may reflect the difficulty of detecting low-level or cleared infections, or differences in the patient populations studied. But it does caution against assuming that every virus loosely linked to PSA elevation is routinely colonizing prostate tissue. In many cases, the mechanism is probably systemic inflammation rather than direct infection of the gland.
This distinction matters because it shapes how doctors think about the problem. If a virus raises PSA by infecting the prostate directly, you might expect the elevation to persist until the virus is cleared. If the PSA rise is driven by circulating inflammatory signals from an infection elsewhere in the body, it should resolve once the immune response calms down, regardless of whether the virus ever touched the prostate. The EBV data strongly supports the systemic-inflammation pathway, while HHV-8 and CMV appear to involve both direct and indirect effects.
Practical Timing for PSA Testing Around Illness
If you have a scheduled PSA test coming up and you are currently fighting off a virus, or recently recovered from one, the most practical advice is to postpone the blood draw. There is no universally agreed-upon waiting period, but most experts suggest waiting at least four to six weeks after symptoms resolve before testing. For more severe infections like COVID-19 or mononucleosis, a longer wait may be wise, since the inflammatory response can take months to fully settle.
When postponing is not an option, for instance if you are in active cancer surveillance and need regular monitoring, make sure your doctor knows about the recent illness. A PSA value interpreted in the context of a known recent infection carries very different weight than the same value in an otherwise healthy man. Your doctor can factor in the timing, compare to your previous trend, and decide whether a recheck in a few weeks is more appropriate than an immediate biopsy.
For men who have already received a surprising PSA result and are trying to figure out what happened, it is worth thinking back over the prior few weeks. Did you have a cold, the flu, COVID, a stomach bug, or any other illness with fever? Did you receive a vaccination? Any of these could plausibly have contributed. Bringing this information to your follow-up appointment helps your doctor make a better-informed decision about next steps.